PALLAS Laser for Skin Diseases

计划入组 50 人 · 首次发布于 2025 年 11 月 26 日

Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial

计划入组 50 人 · 首次发布于 2026 年 2 月 5 日

Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort

计划入组 3,400 人 · 首次发布于 2006 年 6 月 27 日

Gallus gallus feather

PATAS

PalloV-CC

Pillar

NORTH DALLAS DENTAL HEALTH

United States

Pamlab, Inc.

United States

PALLAS Trial: Palbociclib Shows No Benefit in Stage IIA-III HR+ Breast Cancer Treatment

Natera's Signatera MRD Test Shows Powerful Prognostic Value in Phase III PALLAS Breast Cancer Study

CDK4/6 Inhibitors Show Potential in HR+/HER2- Early Breast Cancer Adjuvant Therapy